All In Biotech

Drug Trial Radar · NCT05714891

Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer

Neoadjuvant Platform Trial in Patients With Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)

Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

4

Actual

Start

Sep 15, 2023

Primary completion

Dec 31, 2026

Study completion Mar 31, 2028

Sponsor

Lead sponsor
Canadian Cancer Trials GroupResearch network
Sponsor type
Research network
Collaborators
Novartis
First posted
Feb 6, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being done to answer the following question: What are the effects of new treatments on non-small cell lung cancer before surgery?

Conditions

  • NSCLC

Interventions

  • JDQ443Drug

    Dose will be assigned at enrollment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Identify promising neoadjuvant treatment regimens for NSCLC for later validation in randomized clinical trials, by evaluating major pathological response rates (MPR)Time frame: 3 years

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • CancerCare Manitoba

    Winnipeg, Manitoba, Canada

  • Kingston Health Sciences Centre

    Kingston, Ontario, Canada

  • London Health Sciences Centre Research Inc.

    London, Ontario, Canada

  • Ottawa Hospital Research Institute

    Ottawa, Ontario, Canada

  • University Health Network

    Toronto, Ontario, Canada

  • CHUM-Centre Hospitalier de l'Universite de Montreal

    Montreal, Quebec, Canada

  • The Research Institute of the McGill University

    Montreal, Quebec, Canada

  • University Institute of Cardiology and

    Québec, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.